Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-17

Clinical Trial Update: Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for IPF [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update assessing the safety of intravenously infused cultured allogeneic umbilical cord-derived mesenchymal stem cells in idiopathic pulm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cultured allogeneic adult umbilical cord-derived mesenchymal stem cells

Snippet

Sponsor: The Foundation for Orthopaedics and Regenerative Medicine | Conditions: Idiopathic Pulmonary Fibrosis | Phase 1 | Status: RECRUITING